Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Phase 4 Field Study for Analyzing the Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Lung Cancer (EORTC QLQ-LC29)

NCT02745691 is registered in ClinicalTrials.gov with University Hospital Regensburg as lead sponsor.

NCT NCT02745691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02745691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Phase 4 Field Study for Analyzing the Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Lung Cancer (EORTC QLQ-LC29)
Lead sponsor
University Hospital Regensburg
Phase
Observational
Overall status
Completed
Start date
April 1, 2016
Completion date
September 26, 2018
Enrollment
523 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer